Francesca Maria Quaglia

14PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Apr 02, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study.

Francesca Maria Quaglia, Lara Mannelli, Luca Pagliaro

|Dec 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|Jun 25, 2025
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes.

Sara Pepe, Candida Vitale, Diana Giannarelli

|Jan 08, 2025
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.

Francesca Perutelli, Elia Boccellato, Maria Chiara Montalbano

|Oct 16, 2024
Visceral Leishmaniasis Following A+AVD Treatment in a Patient with Classical Hodgkin's Lymphoma: A Case Report and Review of the Literature.

Daniela Estefania Banegas, Alessia Moioli, Eleonora Santoni

Pageof 3

Frequent Collaborators

9 joint publications

Carlo Visco

4 joint publications

Stefan Hohaus

4 joint publications

Riccardo Moia

3 joint publications

Piero Maria Stefani